欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	NL/H/1425/010
药品名称	Olanzapine Ranbaxy 2,5 mg tablets
活性成分	olanzapine 2.5 mg
剂型	Tablet
上市许可持有人	RANBAXY BELGIUM N.V. 1800 VILVOORDE, LEUVENSESTRAAT 28/2 BELGIUM
参考成员国 - 产品名称	Netherlands (NL)
互认成员国 - 产品名称	France (FR) Spain (ES) Poland (PL) Olanzapine Lekam Romania (RO) Olanzapina Terapia 20 mg comprimate orodispersabile Germany (DE)
许可日期	2009/06/28
最近更新日期	2022/11/11
药物ATC编码	N05AH03 olanzapine
申请类型	TypeLevel1：Abridged TypeLevel2：Additional Strength/Form TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	Final SPC \| common-combined-commonsmpcodsclean0008Date of last change:2020/07/21 Final SPC \| common-combined-commonsmpctabclean0008Date of last change:2020/07/21 Final PL \| common-combined-commonplodsclean0008Date of last change:2020/07/21 Final PL \| common-combined-commonpltabclean0008Date of last change:2020/07/21 Final Product Information \| common-pl-olanzapineranbaxytab1425cleanDate of last change:2017/04/11 Final Product Information \| common-spc-olanzapineranbaxyod1425cleanDate of last change:2017/04/11 Final Product Information \| common-pl-olanzapineranbaxyodt1425cleanDate of last change:2017/04/11 Final Product Information \| common-spc-olanzanpineranbaxytab1425cleanDate of last change:2017/04/11
市场状态	Positive